GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PD-RX Pharmaceuticals Inc (OTCPK:PDRX) » Definitions » Net Income From Continuing Operations

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Net Income From Continuing Operations : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is PD-RX Pharmaceuticals Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. PD-RX Pharmaceuticals's net income from continuing operations for the three months ended in . 20 was $0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

PD-RX Pharmaceuticals Net Income From Continuing Operations Historical Data

The historical data trend for PD-RX Pharmaceuticals's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PD-RX Pharmaceuticals Net Income From Continuing Operations Chart

PD-RX Pharmaceuticals Annual Data
Trend
Net Income From Continuing Operations

PD-RX Pharmaceuticals Quarterly Data
Net Income From Continuing Operations

PD-RX Pharmaceuticals Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PD-RX Pharmaceuticals Inc (OTCPK:PDRX) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:536565 TSXV:MNX BOM:530697 STU:BMP HKSE:00401 HKSE:08372 SNYR ISX:SDPC BOM:540695 FZMD XMAD:MED HKSE:00858 TSXV:KDA BKK:TM ROCO:6637 TSE:9265 BKK:EFORL TSE:7681 TSE:2689 XLJU:SALR
Traded in Other Exchanges
N/A
Address
727 North Ann Arbor Avenue, Oklahoma City, OK, USA, 73127-5822
Website
https://www.pdrx.com
PD-RX Pharmaceuticals Inc provides and distributes a complete line of brand and generic pharmaceuticals, unit dose products, unit of use, injectables, creams, ointments, and medical and surgical supplies.

PD-RX Pharmaceuticals (PD-RX Pharmaceuticals) Headlines

From GuruFocus

PD-Rx Declares Dividend

By PRNewswire PRNewswire • 05-07-2018

PD-Rx Declares Dividend

By PRNewswire PRNewswire • 12-06-2018